SCHEMBL18172092

SCHEMBL18172092

N#CCC(=O)Nc1ccc(I)cn1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
MKNK1 Q9BUB5 1/20 0.41
ABL1 P00519 4/20 0.40
USP30 Q70CQ3 1/20 0.40
TSHR P16473 1/20 0.40
MAP4K1 Q92918 1/20 0.39
DEGS1 O15121 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
JAK2 O60674 1/20 0.39
JAK3 P52333 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
HSD17B10 Q99714 2/20 0.39
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31165861 0.81 AR (0.48) DEGS1SMN1; SMN2KDM4EMEN1KMT2A
SCHEMBL9191562 0.81 TSHR (0.61) TSHRSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL9191455 0.81 TDP1 (0.63) TDP1TSHRSMN1; SMN2ALDH1A1HTT
SCHEMBL31357331 0.81 TSHR (0.61) TSHRSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL26653746 0.79 HSD17B10 (0.54) TDP1TSHRDEGS1SMN1; SMN2ALDH1A1
SCHEMBL16230884 0.79 TSHR (0.46) TDP1TSHRDEGS1SMN1; SMN2ALDH1A1
SCHEMBL9188600 0.78 RAB9A (0.53) DEGS1SMN1; SMN2KDM4ERAB9A
SCHEMBL9188906 0.77 CYP1A2 (0.61) SMN1; SMN2KDM4EALDH1A1MEN1KMT2A
SCHEMBL3408832 0.76 TSHR (0.68) TSHRDEGS1SMN1; SMN2RAB9A
SCHEMBL9206404 0.75 CA12 (0.63) CA12CA1CA2CA9ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3286178-A1 AMINO-SUBSTITUTED HETEROCYCLIC DERIVATIVES AS SODIUM CHANNEL INHIBITORS Almirall S.A. (ES) 2018-02-28 EP disclosed
WO-2016170009-A1 AMINO-SUBSTITUTED HETEROCYCLIC DERIVATIVES AS SODIUM CHANNEL INHIBITORS ALMIRALL, S.A. (ES) 2016-10-27 WO disclosed